Eyes and vision
7 results
Applied filters
Preparing to use aflibercept 2mg biosimilar
10 December 2025Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.
The licence and supporting evidence for aflibercept biosimilars
28 November 2025Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
In-use shelf life of eye drops and ointments
17 November 2025In use expiry dates of eye preparations should be assigned to minimise the risk of microbial contamination and proliferation
Preparing to use ranibizumab biosimilar
5 November 2025Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
The licence and supporting evidence for ranibizumab biosimilars
5 November 2025Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
Supporting people with sight loss in managing their medicines
20 March 2025Guidance for pharmacy staff about how to support people with sight loss in using their medicines and accessing pharmacy services.
Using chloramphenicol during breastfeeding
12 April 2023Topical chloramphenicol can be used with caution and monitoring. Systemic chloramphenicol is not recommended. Advice applies to full term and healthy infants.